- Home
- SRM vs MYNZ Comparison
SRM vs MYNZ Comparison
Compare SRM & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRM
- MYNZ
- Stock Information
- Founded
- SRM 1979
- MYNZ 2021
- Country
- SRM United States
- MYNZ Germany
- Employees
- SRM N/A
- MYNZ N/A
- Industry
- SRM
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- SRM
- MYNZ Health Care
- Exchange
- SRM Nasdaq
- MYNZ Nasdaq
- Market Cap
- SRM 9.0M
- MYNZ 8.0M
- IPO Year
- SRM 2023
- MYNZ 2021
- Fundamental
- Price
- SRM $0.81
- MYNZ $2.08
- Analyst Decision
- SRM
- MYNZ Buy
- Analyst Count
- SRM 0
- MYNZ 2
- Target Price
- SRM N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- SRM 540.8K
- MYNZ 93.5K
- Earning Date
- SRM 05-09-2025
- MYNZ 06-17-2025
- Dividend Yield
- SRM N/A
- MYNZ N/A
- EPS Growth
- SRM N/A
- MYNZ N/A
- EPS
- SRM N/A
- MYNZ N/A
- Revenue
- SRM $4,394,659.00
- MYNZ $893,991.00
- Revenue This Year
- SRM N/A
- MYNZ $26.06
- Revenue Next Year
- SRM N/A
- MYNZ $4.97
- P/E Ratio
- SRM N/A
- MYNZ N/A
- Revenue Growth
- SRM N/A
- MYNZ N/A
- 52 Week Low
- SRM $0.26
- MYNZ $1.92
- 52 Week High
- SRM $1.66
- MYNZ $34.00
- Technical
- Relative Strength Index (RSI)
- SRM 79.44
- MYNZ 38.07
- Support Level
- SRM $0.54
- MYNZ $1.93
- Resistance Level
- SRM $0.66
- MYNZ $2.10
- Average True Range (ATR)
- SRM 0.07
- MYNZ 0.16
- MACD
- SRM 0.02
- MYNZ 0.04
- Stochastic Oscillator
- SRM 99.75
- MYNZ 30.39
About SRM SRM Entertainment Inc.
SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.